Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
IL-12 stimulant
DRUG CLASS:
IL-12 stimulant
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
INO-9012 (1)
ADV/IL-12 gene therapy (0)
AGX-148 (0)
Ad-RTS-hIL-12 (0)
CARG-2020 (0)
CLN-617 (0)
DF6002 (0)
GX-051 (0)
rHuIL-12 (0)
IMNN-001 (0)
JCAR020 (0)
MEDI0457 (0)
MEDI1191 (0)
MEDI9253 (0)
MVR-C5252 (0)
MVR-T7011 (0)
ONCR-177 (0)
PDS01ADC (0)
RTX-224 (0)
RTX-321 (0)
SAR441000 (0)
SENTI-101 (0)
SON-1010 (0)
T3011 (0)
TBio-6517 (0)
TG6050 (0)
tavokinogene telsaplasmid (0)
AV0113 (0)
VG161 (0)
VG201 (0)
WTX-330 (0)
XTX301 (0)
EG-70 (0)
F8-IL12 (0)
INO-9012 (1)
ADV/IL-12 gene therapy (0)
AGX-148 (0)
Ad-RTS-hIL-12 (0)
CARG-2020 (0)
CLN-617 (0)
DF6002 (0)
GX-051 (0)
rHuIL-12 (0)
IMNN-001 (0)
JCAR020 (0)
MEDI0457 (0)
MEDI1191 (0)
MEDI9253 (0)
MVR-C5252 (0)
MVR-T7011 (0)
ONCR-177 (0)
PDS01ADC (0)
RTX-224 (0)
RTX-321 (0)
SAR441000 (0)
SENTI-101 (0)
SON-1010 (0)
T3011 (0)
TBio-6517 (0)
TG6050 (0)
tavokinogene telsaplasmid (0)
AV0113 (0)
VG161 (0)
VG201 (0)
WTX-330 (0)
XTX301 (0)
EG-70 (0)
F8-IL12 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
MGMT unmethylation
Glioblastoma
MGMT unmethylation
Glioblastoma
cemiplimab-rwlc + INO-5401 + INO-9012
Sensitive: C3 – Early Trials
cemiplimab-rwlc + INO-5401 + INO-9012
Sensitive
:
C3
cemiplimab-rwlc + INO-5401 + INO-9012
Sensitive: C3 – Early Trials
cemiplimab-rwlc + INO-5401 + INO-9012
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login